The effects of consumption of interesterified fats rich in palmitic acid compared with stearic acid on intermediary markers of cardiometabolic disease risk: a randomized controlled trial in healthy adults
The American Journal of Clinical Nutrition · 2025
DOI: 10.1016/j.ajcnut.2025.09.025 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The American Journal of Clinical Nutrition, 2025. Verfasst von Wendy L Hall und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, School of Life Course and Population Sciences, King's College London, United Kingdom. Electronic address: wendy.h…. Hauptthemen laut MEDLINE: Palmitic Acid, Stearic Acids, Dietary Fats, Cardiovascular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Malaysian Palm Oil Board.
Abstract (Originalsprache)
BACKGROUND: Interesterified (IE) fats rich in palmitic acid (16:0) and stearic acid (18:0) are widely used hard fats. Comparative effects of commercially relevant palmitic or stearic acid-rich IE fat blends on cardiometabolic disease (CMD) risk markers remain unclear. It was hypothesized that functionally matched palmitic and stearic acid-rich fats would have equivalent effects on plasma total:high-density lipoprotein (HDL) cholesterol ratio within a predefined equivalence margin of ±0.09. OBJECTIVES: This study aimed to compare the effects of diets enriched in palmitic or stearic acid, delivered as commercially relevant IE fats and incorporated at realistic levels of dietary intake, on plasma lipid concentrations and other CMD risk markers in healthy participants. METHODS: In a randomized, crossover trial at 2 centers, 51 healthy participants (aged 35-65 y) consumed diets with either palmitic acid-rich or stearic acid-rich IE fats (10% energy intake) for 6 wk per arm, with a 4-wk washout. IE fats were incorporated into muffins and margarine spreads. The primary outcome was total:HDL cholesterol ratio; secondary outcomes included HDL and low-density lipoprotein cholesterol and fasting and postprandial triacylglycerol, lipoproteins, apolipoproteins, insulin sensitivity, vascular endothelial function, inflammation markers, and fasting liver fat (via proton magnetic resonance spectroscopy, subgroup). Linear mixed models were used to assess intervention effects. RESULTS: Forty-seven participants (51% female, mean age 52 ± 8 y; body mass index 25.2 ± 2.8 kg/m2) completed the study. No significant differences were observed in total:HDL cholesterol ratio between interventions (stearic compared with palmitic mean difference: 0.05; 95% confidence interval [CI]: -0.08, 0.18). Interleukin-10 concentration decreased after consuming palmitic relative to stearic acid-rich IE fats (-0.14 ng/L; 95% CI: -0.23, -0.06 ng/L). No effects were observed on other outcomes. CONCLUSIONS: Commercially relevant palmitic acid-rich IE fats consumed at 10% energy for a 6-wk period do not adversely affect total:HDL cholesterol ratio or other CMD risk markers compared with stearic acid-rich fats. Long-term effects could not be determined from this trial. This trial was registered at clinicaltrials.gov as NCT04418102.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Sciences, School of Life Course and Population Sciences, King's College London, United Kingdom. Electronic address: wendy.hall@kcl.ac.uk.
- Department of Nutritional Sciences, School of Life Course and Population Sciences, King's College London, United Kingdom.
- Department of Nutrition and Movement Sciences, NUTRIM Institute of Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, The Netherlands.
- Department of Nutritional Sciences, School of Life Course and Population Sciences, King's College London, United Kingdom; Centre for Nutrition, Exercise, and Metabolism, Department for Health, University of Bath, Bath,…
- ADM UK Ltd, Erith, United Kingdom.
Förderung
- Malaysian Palm Oil Board
Zitieren
APA
Hall, W. L., Wood, E., Joris, P. J., Smith, H. A., Creedon, A., Maher, T., Bruce, J. H., Mensink, R. P., & Berry, S. E. (2025). The effects of consumption of interesterified fats rich in palmitic acid compared with stearic acid on intermediary markers of cardiometabolic disease risk: a randomized controlled trial in healthy adults. The American Journal of Clinical Nutrition. https://doi.org/10.1016/j.ajcnut.2025.09.025
Vancouver
Hall WL, Wood E, Joris PJ, Smith HA, Creedon A, Maher T, et al. The effects of consumption of interesterified fats rich in palmitic acid compared with stearic acid on intermediary markers of cardiometabolic disease risk: a randomized controlled trial in healthy adults. The American Journal of Clinical Nutrition. 2025. doi:10.1016/j.ajcnut.2025.09.025
BibTeX
@article{Hall2025,
author = {Hall, Wendy L and Wood, Eleanor and Joris, Peter J and Smith, Harry A and Creedon, Alice and Maher, Tyler and Bruce, Johanna H and Mensink, Ronald P and Berry, Sarah E},
title = {The effects of consumption of interesterified fats rich in palmitic acid compared with stearic acid on intermediary markers of cardiometabolic disease risk: a randomized controlled trial in healthy adults},
journal = {The American Journal of Clinical Nutrition},
year = {2025},
doi = {10.1016/j.ajcnut.2025.09.025}
}
EUVIMED